Annual CFF
-$41.81 M
-$47.33 M-858.43%
31 December 2023
Summary:
Cytek Biosciences annual cash flow from financing activities is currently -$41.81 million, with the most recent change of -$47.33 million (-858.43%) on 31 December 2023. During the last 3 years, it has fallen by -$164.42 million (-134.10%). CTKB annual CFF is now -119.58% below its all-time high of $213.56 million, reached on 31 December 2021.CTKB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$12.08 M
-$10.37 M-606.25%
30 September 2024
Summary:
Cytek Biosciences quarterly cash flow from financing activities is currently -$12.08 million, with the most recent change of -$10.37 million (-606.25%) on 30 September 2024. Over the past year, it has dropped by -$3.81 million (-46.05%). CTKB quarterly CFF is now -105.57% below its all-time high of $217.08 million, reached on 30 September 2021.CTKB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$45.94 M
-$3.81 M-9.04%
30 September 2024
Summary:
Cytek Biosciences TTM cash flow from financing activities is currently -$45.94 million, with the most recent change of -$3.81 million (-9.04%) on 30 September 2024. Over the past year, it has dropped by -$41.73 million (-991.63%). CTKB TTM CFF is now -113.78% below its all-time high of $333.27 million, reached on 30 September 2021.CTKB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -858.4% | -46.0% | -991.6% |
| 3 y3 years | -134.1% | -105.6% | -113.8% |
| 5 y5 years | - | - | - |
CTKB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -119.6% | at low | -105.6% | +64.2% | -113.8% | at low |
| 5 y | 5 years | -119.6% | at low | -105.6% | +64.2% | -113.8% | at low |
| alltime | all time | -119.6% | at low | -105.6% | +64.2% | -113.8% | at low |
Cytek Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.08 M(+606.3%) | -$45.94 M(+9.0%) |
| June 2024 | - | -$1.71 M(-206.1%) | -$42.13 M(+4.8%) |
| Mar 2024 | - | $1.61 M(-104.8%) | -$40.20 M(-3.9%) |
| Dec 2023 | -$41.81 M(-858.4%) | -$33.75 M(+308.0%) | -$41.81 M(+893.6%) |
| Sept 2023 | - | -$8.27 M(-3930.6%) | -$4.21 M(-199.7%) |
| June 2023 | - | $216.00 K(>+9900.0%) | $4.22 M(-18.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $5.15 M(-6.6%) |
| Dec 2022 | $5.51 M | $3.85 M(+2383.9%) | $5.51 M(+228.2%) |
| Sept 2022 | - | $155.00 K(-86.5%) | $1.68 M(-99.2%) |
| June 2022 | - | $1.14 M(+214.3%) | $218.60 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $364.00 K(+2041.2%) | $213.74 M(+0.1%) |
| Dec 2021 | $213.56 M(+74.2%) | $17.00 K(-100.0%) | $213.56 M(-35.9%) |
| Sept 2021 | - | $217.08 M(-5930.7%) | $333.27 M(+189.9%) |
| June 2021 | - | -$3.72 M(-2090.9%) | $114.98 M(-6.4%) |
| Mar 2021 | - | $187.00 K(-99.8%) | $122.78 M(+0.1%) |
| Dec 2020 | $122.61 M(>+9900.0%) | $119.73 M(<-9900.0%) | $122.61 M(+4157.2%) |
| Sept 2020 | - | -$1.22 M(-129.8%) | $2.88 M(-29.7%) |
| June 2020 | - | $4.08 M(>+9900.0%) | $4.09 M(>+9900.0%) |
| Mar 2020 | - | $13.00 K | $13.00 K |
| Dec 2019 | $93.00 K | - | - |
FAQ
- What is Cytek Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Cytek Biosciences?
- What is Cytek Biosciences annual CFF year-on-year change?
- What is Cytek Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cytek Biosciences?
- What is Cytek Biosciences quarterly CFF year-on-year change?
- What is Cytek Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cytek Biosciences?
- What is Cytek Biosciences TTM CFF year-on-year change?
What is Cytek Biosciences annual cash flow from financing activities?
The current annual CFF of CTKB is -$41.81 M
What is the all time high annual CFF for Cytek Biosciences?
Cytek Biosciences all-time high annual cash flow from financing activities is $213.56 M
What is Cytek Biosciences annual CFF year-on-year change?
Over the past year, CTKB annual cash flow from financing activities has changed by -$47.33 M (-858.43%)
What is Cytek Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of CTKB is -$12.08 M
What is the all time high quarterly CFF for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash flow from financing activities is $217.08 M
What is Cytek Biosciences quarterly CFF year-on-year change?
Over the past year, CTKB quarterly cash flow from financing activities has changed by -$3.81 M (-46.05%)
What is Cytek Biosciences TTM cash flow from financing activities?
The current TTM CFF of CTKB is -$45.94 M
What is the all time high TTM CFF for Cytek Biosciences?
Cytek Biosciences all-time high TTM cash flow from financing activities is $333.27 M
What is Cytek Biosciences TTM CFF year-on-year change?
Over the past year, CTKB TTM cash flow from financing activities has changed by -$41.73 M (-991.63%)